- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01425983
Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01) (asn01)
Dietary Intervention of Stress-Induced Neurovegetative Disorders in Men and Women With a Specific Amino Acid Composition With Micronutrients
Psychosocial stress leads to altered neuroendocrine functions, such as serotonergic dysfunction, as well as alterations of the autonomic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis activity resulting in an imbalance between inhibitory and excitatory neurotransmitters. Clinical consequences include, inter alia, neurovegetative disorders, higher resting heart rate, hypertension, depressive symptoms, sleep disturbances, irregular body-weight changes, and insulin resistance. Poor dietary intake of the essential amino acid L-tryptophane as a precursor to 5-hydroxytryptamine (HT, serotonin) increases sensitivity to stress.
It is therefore the investigators hypothesis that daily oral administration of an amino acid mixture (dosage 3.8 g/day) with micronutrients specifically designed to decrease neurovegetative disorders will target these neuroendocrine and metabolic alterations in adults with psychosocial stress. The principal endpoints will be a decrease in points in the psychological-neurological questionnaire (PNF).
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 13053
- Cardiological Outpatient Practice Elke Parsi, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: 18-65 Years
- Psychological-Neurological Questionnaire (PNF): 30 - 50 Points
Exclusion Criteria:
- Age: < 18 and > 65 Years
- Psychological neurological questionnaire (PNF): < 30 and > 50 Points
- Resting heart rate: < 70/min
- Supplementation with dietary supplements or drugs which contains amino acids, vitamins and other micronutrients
- Therapy with antipsychotic drugs such as tranquilizer, antidepressants
- acute and chronic diarrhea
- Psychological-neurological or psychiatric therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: amino acid composition (asn01)
Dietary supplement: specific amino acid composition with micronutrients
|
Amino acid composition with micronutrients, once a day (in the evening, 2 hours after dinner) content of a sachet mixed with 200 ml water. Duration: 12 weeks
Other Names:
|
|
PLACEBO_COMPARATOR: Sugar powder
Placebo contains no amino acids and no micronutrients and is identical in appearance and solution properties.
|
Placebo; once a day (in the evening, 2 hours after dinner) content of a sachet mixed with 200 ml water. Placebo contains no amino acids and micronutrients and is identical in appearance and solution properties. Duration: 12 weeks |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological neurological questionnaire (PNF)
Time Frame: 12-week dietary intervention
|
Pre-post intervention changes in total number of points PNF
|
12-week dietary intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological neurological questionnaire (PNF)
Time Frame: 12-week dietary intervention
|
Pre-post improvement in total number of points from the psychological-neurological questionnaire (PNF) about 10 Points or more
|
12-week dietary intervention
|
|
Salivary cortisol concentration (30 minutes after waking in the morning)
Time Frame: 12-week dietary intervention
|
Absolute difference between cortisol concentration at baseline and 12 weeks
|
12-week dietary intervention
|
|
Salivary cortisol concentration (in the evening between 8 and 10 pm, 2 hours after dinner)
Time Frame: 12-week dietary intervention
|
Absolute difference between cortisol concentration at baseline and 12 weeks
|
12-week dietary intervention
|
|
Serotonin concentration in blood
Time Frame: 12-week dietary intervention
|
Absolute difference between serotonin concentration at baseline and 12 weeks
|
12-week dietary intervention
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Kyberg-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nervous System Disorder
-
Life UniversityEnrolling by invitationDysautonomia | Dysautonomia Like DisorderPakistan
-
Istanbul Medipol University HospitalCompletedVagus Nerve Autonomic DisorderTurkey
-
Imagine InstituteNot yet recruitingCentral Nervous System Diseases | Neurologic DisorderFrance
-
Neurogen Brain and Spine InstituteWithdrawn
-
Abant Izzet Baysal UniversityNot yet recruiting
-
Fondation Ellen PoidatzRecruiting
-
Chung-Ang University Gwangmyeong HospitalNot yet recruitingNeurologic Disorder
-
Medical University of ViennaNeurologisches Rehabiliationszentrum RosenhügelRecruitingNeurologic DisorderAustria
-
Rehabilitation Hospital of Overland ParkDiscovery StatisticsRecruitingNeurologic DisorderUnited States
-
Forest Hills LabLiberyx Therapeutics Ltd.CompletedNeurological DisorderUnited States
Clinical Trials on amino acid composition (asn01)
-
Massachusetts General HospitalNational Institutes of Health (NIH)Withdrawn
-
Kyberg Vital GmbHCompletedto Improve the Effectiveness of a Amino Acid Dietary Supplement in Chronic Pharyngeal Infections vs PlaceboGermany
-
Research Institute of Child Nutrition, DortmundUniversity of Potsdam; Dr. von Hauner Children's Hospital, Germany; Pediatric...Completed
-
Instituto Nacional de Ciencias Medicas y Nutricion...UnknownLiver Cirrhosis | AscitesMexico
-
TNOMinistry of Health, Welfare and SportCompleted
-
Marmara UniversityCompletedBody Composition and Non-small Cell Lung CancerTurkey
-
Anne-Françoise RousseauRecruitingCritical Illness | Major Abdominal SurgeriesBelgium
-
Société des Produits Nestlé (SPN)Completed
-
Leeds Beckett UniversityNot yet recruitingRheumatoid Arthritis | Muscle Atrophy